KA

Kumari Anjali

Active Director Director DIN 11496808
DIN 11496808 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumari Anjali

Data last updated:

Kumari Anjali is a Director at Deasecure Pharmaceuticals Private Limited (since 2026). The company operates in Healthcare.

DIN 11496808
Primary Designation Director
Industry Healthcare
First Appointment 21 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 2026Active

Directorship timeline

Open interactive timeline →
Deasecure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kumari Anjali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Anjali

Kumari Anjali currently holds 1 directorship: Deasecure Pharmaceuticals Private Limited (Director, since 21 Jan 2026).

Kumari Anjali was first appointed on 21 Jan 2026 as Director at Deasecure Pharmaceuticals Private Limited.

The current boards of Kumari Anjali's companies include Anupam Khandelwal (Deasecure Pharmaceuticals Private Limited), Chandan Kumar Singh (Deasecure Pharmaceuticals Private Limited), Khushbu Kumari (Deasecure Pharmaceuticals Private Limited), Kumar Gaurav (Deasecure Pharmaceuticals Private Limited), Priya Bharti (Deasecure Pharmaceuticals Private Limited), Swati Kumari (Deasecure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available